Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19

Affiliations

¹ AP-HP, Sorbonne Université, Pitié-Salpêtrière Hospital, Department of Pharmacology and Clinical Investigation Centre, Paris 75013, France; INSERM, CIC-1901 and UMR-S 1166, Sorbonne Université, Faculty of Medicine, Paris, France. Electronic address: christian.funck-brentano@aphp.fr.
² AP-HP, Sorbonne Université, Pitié-Salpêtrière Hospital, Department of Pharmacology and Clinical Investigation Centre, Paris 75013, France; INSERM, CIC-1901 and UMR-S 1166, Sorbonne Université, Faculty of Medicine, Paris, France.

Christian Funck-Brentano et al. Lancet. 2020.

. 2020 Jul 18;396(10245):e2-e3.

doi: 10.1016/S0140-6736(20)31528-2. Epub 2020 Jul 9.

¹ AP-HP, Sorbonne Université, Pitié-Salpêtrière Hospital, Department of Pharmacology and Clinical Investigation Centre, Paris 75013, France; INSERM, CIC-1901 and UMR-S 1166, Sorbonne Université, Faculty of Medicine, Paris, France. Electronic address: christian.funck-brentano@aphp.fr.
² AP-HP, Sorbonne Université, Pitié-Salpêtrière Hospital, Department of Pharmacology and Clinical Investigation Centre, Paris 75013, France; INSERM, CIC-1901 and UMR-S 1166, Sorbonne Université, Faculty of Medicine, Paris, France.

No abstract available

Retraction of

RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
Mehra MR, Desai SS, Ruschitzka F, Patel AN. Mehra MR, et al. Lancet. 2020 May 22:S0140-6736(20)31180-6. doi: 10.1016/S0140-6736(20)31180-6. Online ahead of print. Lancet. 2020. Retraction in: Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6. Retraction in: Lancet. 2020 Jul 18;396(10245):e2-e3. doi: 10.1016/S0140-6736(20)31528-2. PMID: 32450107 Free PMC article. Retracted.
Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?
Funck-Brentano C, Salem JE. Funck-Brentano C, et al. Lancet. 2020 May 22:S0140-6736(20)31174-0. doi: 10.1016/S0140-6736(20)31174-0. Online ahead of print. Lancet. 2020. Retraction in: Lancet. 2020 Jul 18;396(10245):e2-e3. doi: 10.1016/S0140-6736(20)31528-2. PMID: 32450109 Free PMC article. Retracted. No abstract available.

1. Mehra MR, Desai SS, Ruschitzka F, Patel AN. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020 doi: 10.1016/S0140-6736(20)31180-6. published online May 22. - DOI - PMC - PubMed
1. Funck-Brentano C, Salem J-E. RETRACTED: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? Lancet. 2020 doi: 10.1016/S0140-6736(20)31174-0. published online May 22. - DOI - PMC - PubMed
1. White NJ. Cardiotoxicity of antimalarial drugs. Lancet Infect Dis. 2007;7:549–558. - PubMed
1. Sarganas G, Garbe E, Klimpel A, Hering RC, Bronder E, Haverkamp W. Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany. Europace. 2014;16:101–108. - PubMed
1. Roden DM, Anderson ME. Proarrhythmia. Handb Exp Pharmacol. 2006;171:73–97. - PubMed